Anika Therapeutics Inc (ANIK)
24.99
-0.29
(-1.15%)
USD |
NASDAQ |
Oct 04, 16:00
25.00
+0.01
(+0.04%)
After-Hours: 20:00
Anika Therapeutics Research and Development Expense (Annual): 32.69M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 32.69M |
| December 31, 2022 | 28.18M |
| December 31, 2021 | 27.33M |
| December 31, 2020 | 23.43M |
| December 31, 2019 | 16.66M |
| December 31, 2018 | 18.19M |
| December 31, 2017 | 18.79M |
| December 31, 2016 | 10.73M |
| December 31, 2015 | 8.987M |
| December 31, 2014 | 8.144M |
| December 31, 2013 | 7.06M |
| December 31, 2012 | 5.388M |
| December 31, 2011 | 6.169M |
| December 31, 2010 | 6.875M |
| December 31, 2009 | 8.182M |
| December 31, 2008 | 7.399M |
| Date | Value |
|---|---|
| December 31, 2007 | 4.365M |
| December 31, 2006 | 3.616M |
| December 31, 2005 | 4.731M |
| December 31, 2004 | 4.087M |
| December 31, 2003 | 2.595M |
| December 31, 2002 | 3.928M |
| December 31, 2001 | 4.280M |
| December 31, 2000 | 3.26M |
| December 31, 1999 | 4.154M |
| December 31, 1998 | 2.00M |
| December 31, 1997 | 2.00M |
| December 31, 1996 | |
| August 31, 1996 | 1.60M |
| August 31, 1995 | 1.30M |
| August 31, 1994 | 1.50M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
16.66M
Minimum
2019
32.69M
Maximum
2023
25.66M
Average
27.33M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Perspective Therapeutics Inc | 21.31M |
| Electromed Inc | 0.656M |
| Xtant Medical Holdings Inc | 1.336M |
| Myomo Inc | 2.636M |
| Catheter Precision Inc | 0.475M |